標(biāo)題: Titlebook: Gene Therapy of Solid Cancers; Methods and Protocol Wolfgang Walther,Ulrike Stein Book 2015 Springer Science+Business Media New York 2015 c [打印本頁(yè)] 作者: 可怖 時(shí)間: 2025-3-21 18:04
書(shū)目名稱(chēng)Gene Therapy of Solid Cancers影響因子(影響力)
書(shū)目名稱(chēng)Gene Therapy of Solid Cancers影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Gene Therapy of Solid Cancers網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Gene Therapy of Solid Cancers網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Gene Therapy of Solid Cancers被引頻次
書(shū)目名稱(chēng)Gene Therapy of Solid Cancers被引頻次學(xué)科排名
書(shū)目名稱(chēng)Gene Therapy of Solid Cancers年度引用
書(shū)目名稱(chēng)Gene Therapy of Solid Cancers年度引用學(xué)科排名
書(shū)目名稱(chēng)Gene Therapy of Solid Cancers讀者反饋
書(shū)目名稱(chēng)Gene Therapy of Solid Cancers讀者反饋學(xué)科排名
作者: Encephalitis 時(shí)間: 2025-3-21 23:56
Use of GLV-1h68 for Vaccinia Virotherapy and Monitoringase-fluorescent protein fusion gene, bacterial beta-galactosidase, as well as a bacterial glucuronidase..The methods to investigate and monitor GLV-1h68 mediated virotherapy, including optical imaging and biomarker analysis, will be presented in detail.作者: 胰島素 時(shí)間: 2025-3-22 03:51
1064-3745 ation advice from the experts.This volume provides insight into recent developments on experimental and clinical strategies for cancer gene therapy. .Gene Therapy of Solid Cancers: Methods and Protocols. guides readers through. .protocols on gene therapeutic strategies in combination with helpful te作者: Graduated 時(shí)間: 2025-3-22 07:08 作者: 無(wú)可爭(zhēng)辯 時(shí)間: 2025-3-22 11:18 作者: 公豬 時(shí)間: 2025-3-22 14:39
Climate Risk and Organizational Challenges,te Her2/neu DNA vaccines in different settings, i.e., intramuscular or intradermal application with or without coexpression of adjuvants. Protection from tumor growth in tumor challenge experiments and both T cell and humoral immune responses against Her2/neu peptides are used as surrogate parameters for vaccine efficacy.作者: 公豬 時(shí)間: 2025-3-22 20:39
https://doi.org/10.1007/978-3-030-61160-6o-stimulatory molecules CD80 and CD154 are expressed at the cell surface, whereas the two cytokines GM-CSF and IL-7 are secreted yielding cells with enhanced immunological properties. These fourfold gene-modified cells have been used as a cell-based tumor vaccine for the treatment of RCC.作者: Ischemic-Stroke 時(shí)間: 2025-3-22 22:08 作者: 圣人 時(shí)間: 2025-3-23 02:18
https://doi.org/10.1007/978-1-4020-5714-4esses for the development of highly potent and selective chemically modified antisense oligodeoxynucleotides (fully phosphorothioate locked nucleic acid gapmers) allowing effective and selective suppression of TGF-β isoform expression in cell-based assays and in vivo preclinical models.作者: 享樂(lè)主義者 時(shí)間: 2025-3-23 08:45 作者: Presbyopia 時(shí)間: 2025-3-23 12:30 作者: 不怕任性 時(shí)間: 2025-3-23 16:23 作者: conference 時(shí)間: 2025-3-23 18:18 作者: 1分開(kāi) 時(shí)間: 2025-3-23 23:23 作者: 揉雜 時(shí)間: 2025-3-24 05:16 作者: Ruptured-Disk 時(shí)間: 2025-3-24 09:38
Book 2015erials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls..Concise and easy-to-use, .Gene Therapy of Solid Cancers: Methods and Protocols. aims to ensure successful results in the further study of this vital field..作者: Irascible 時(shí)間: 2025-3-24 12:24 作者: OREX 時(shí)間: 2025-3-24 16:53 作者: 壟斷 時(shí)間: 2025-3-24 22:09 作者: 西瓜 時(shí)間: 2025-3-25 01:46
Cape Floristic Region, South Africaof tumor growth and metastasis formation over time. End point analysis of the trial included scoring of the metastatic burden and the quantification of target gene expression in the tumor. Average S100A4 expression in tumor tissues was reduced by 30 %, causing a 70 % decrease of liver metastases.作者: creditor 時(shí)間: 2025-3-25 04:17
RNA Interference for Antimetastatic Therapyof tumor growth and metastasis formation over time. End point analysis of the trial included scoring of the metastatic burden and the quantification of target gene expression in the tumor. Average S100A4 expression in tumor tissues was reduced by 30 %, causing a 70 % decrease of liver metastases.作者: 蹣跚 時(shí)間: 2025-3-25 08:03 作者: Vsd168 時(shí)間: 2025-3-25 14:41 作者: 赦免 時(shí)間: 2025-3-25 15:55
Climate Risk and Organizational Challenges,of DNA vaccines, particularly in large animals and humans, different strategies have been pursued. These vaccination strategies are based on different application routes, schedules, and coexpression of immunomodulatory molecules as adjuvants. Our mouse tumor model offers the possibility to investiga作者: 啞劇 時(shí)間: 2025-3-25 21:54
https://doi.org/10.1007/978-3-030-61160-6rposes, like gene correction or production of therapeutics. Here, we describe the generation of a cell-based tumor vaccine via fourfold transient gene modification of a human renal cell carcinoma (RCC) cell line for high expression of CD80, CD154, GM-CSF, and IL-7 by use of MIDGE. vectors. The two c作者: 我不明白 時(shí)間: 2025-3-26 02:37
Ghassem R. Asrar,James W. Hurrellctly activating apoptotic pathways itself or facilitating the activation of pharmacologic agents that do so. The latter class of SGTC approaches is of the greater utility in cancer therapy owing to the ability of some small, activated cytotoxic compounds to diffuse from their site of activation into作者: catagen 時(shí)間: 2025-3-26 04:42 作者: 植物群 時(shí)間: 2025-3-26 10:16 作者: 構(gòu)想 時(shí)間: 2025-3-26 15:20 作者: bourgeois 時(shí)間: 2025-3-26 18:36
Vanesa Castán Broto,Enora Robin,Aidan Whileivo, a quantitation method is needed that exhibits high precision, accuracy, and robustness. While most clinical applications for oligonucleotide therapeutics involve methods based on hybridization assays and liquid chromatography-tandem mass spectrometry, quantitative PCR (qPCR) is a less well-desc作者: 桶去微染 時(shí)間: 2025-3-26 21:51
https://doi.org/10.1007/978-1-4020-5714-4ng tumor cell invasion and migration, angiogenesis, immunosuppression, as well as regulation of tumor stem cell properties. Hence, blocking the TGF-β signaling pathways may have a multifold therapeutic benefit for the treatment of solid tumors. Here, we describe the identification and selection proc作者: Humble 時(shí)間: 2025-3-27 02:57 作者: FANG 時(shí)間: 2025-3-27 06:19
https://doi.org/10.1007/978-3-642-45670-1entiation, proliferation, and survival, and is associated with angiogenesis and immune dysfunction during tumorigenesis. Double-stranded decoy oligodeoxynucleotide (ODN) targeting over-activated STAT3 in tumor cells have shown significant antitumor efficiency. Here, we describe the materials and met作者: Medicare 時(shí)間: 2025-3-27 11:30
https://doi.org/10.1007/978-3-319-99837-4(herceptin) for breast cancer or Iressa (gefitinib) for non-small cell lung cancer among others are limited by lack of efficacy, cellular resistance, and toxicity. Dose escalation and combination therapies designed to overcome resistance and increase efficacy are limited by a narrow therapeutic inde作者: Bouquet 時(shí)間: 2025-3-27 14:12
C. A. Hendriks,K. Blok,W. C. Turkenburgy in more than 50 xenograft tumor models. The recombinant vaccinia virus strain has been equipped with heterologous expression cassettes for a luciferase-fluorescent protein fusion gene, bacterial beta-galactosidase, as well as a bacterial glucuronidase..The methods to investigate and monitor GLV-1h作者: 好開(kāi)玩笑 時(shí)間: 2025-3-27 21:17
C. A. Timmermann,H. van den Belte Memorial Sloan-Kettering Cancer Center, pioneered bacterial therapy of cancer in the clinic with considerable success beginning in the late nineteenth century. After Coley died in 1936, bacterial therapy of cancer essentially ended. Currently there is much excitement in developing bacterial therap作者: coagulate 時(shí)間: 2025-3-27 22:49
Wolfgang Walther,Ulrike SteinIncludes cutting-edge methods and protocols.Provides step-by-step detail essential for reproducible results.Contains key notes and implementation advice from the experts作者: GRILL 時(shí)間: 2025-3-28 04:24
978-1-4939-5592-3Springer Science+Business Media New York 2015作者: 夾克怕包裹 時(shí)間: 2025-3-28 10:06
Gene Therapy of Solid Cancers978-1-4939-2727-2Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: 雕鏤 時(shí)間: 2025-3-28 11:37
Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapyis book chapter we describe the selection and characterization of DNA aptamers specific to the human epidermal growth factor receptor 2 (ERBB2/HER2), an oncogenic tyrosine kinase. First, a DNA aptamer library is applied and ERBB2-specific aptamers are selected using SELEX. Binders are subcloned into作者: amenity 時(shí)間: 2025-3-28 16:06 作者: 巡回 時(shí)間: 2025-3-28 20:04
MIDGE Technology for the Production of a Fourfold Gene-Modified, Allogenic Cell-Based Vaccine for Carposes, like gene correction or production of therapeutics. Here, we describe the generation of a cell-based tumor vaccine via fourfold transient gene modification of a human renal cell carcinoma (RCC) cell line for high expression of CD80, CD154, GM-CSF, and IL-7 by use of MIDGE. vectors. The two c作者: 無(wú)表情 時(shí)間: 2025-3-28 23:26 作者: 馬具 時(shí)間: 2025-3-29 03:26
Oncoleaking: Use of the Pore-Forming , Enterotoxin (CPE) for Suicide Gene Therapyheir therapeutic potential in clinical trials. Apart from this, still growing efforts are made to generate more targeted and more effective suicide gene systems for cancer gene therapy. In this regard bacterial toxins are an alternative, which add to the broad spectrum of different suicide strategie作者: anaerobic 時(shí)間: 2025-3-29 10:40 作者: 颶風(fēng) 時(shí)間: 2025-3-29 14:52 作者: legitimate 時(shí)間: 2025-3-29 19:14
A qRT-PCR Method for Determining the Biodistribution Profile of a miR-34a Mimicivo, a quantitation method is needed that exhibits high precision, accuracy, and robustness. While most clinical applications for oligonucleotide therapeutics involve methods based on hybridization assays and liquid chromatography-tandem mass spectrometry, quantitative PCR (qPCR) is a less well-desc作者: Pastry 時(shí)間: 2025-3-29 21:56 作者: Tidious 時(shí)間: 2025-3-30 00:28
RNA Interference for Antimetastatic Therapyancer disease. Efficient delivery of interfering molecules and their sustained presence in tumor cells are required for therapeutic success. This chapter describes a method of systemic application of shRNA expression plasmid via tail vein injection in xenograft mice, causing the sustained reduction 作者: 混合 時(shí)間: 2025-3-30 04:58
STAT3 Decoy ODN Therapy for Cancerentiation, proliferation, and survival, and is associated with angiogenesis and immune dysfunction during tumorigenesis. Double-stranded decoy oligodeoxynucleotide (ODN) targeting over-activated STAT3 in tumor cells have shown significant antitumor efficiency. Here, we describe the materials and met作者: Dealing 時(shí)間: 2025-3-30 08:21 作者: evaculate 時(shí)間: 2025-3-30 14:40
Use of GLV-1h68 for Vaccinia Virotherapy and Monitoringy in more than 50 xenograft tumor models. The recombinant vaccinia virus strain has been equipped with heterologous expression cassettes for a luciferase-fluorescent protein fusion gene, bacterial beta-galactosidase, as well as a bacterial glucuronidase..The methods to investigate and monitor GLV-1h
